Key result
Major head and neck cancer surgery is linked to a ~6% 30-day VTE incidence.
Why the study?
The incidence of venous thromboembolism following major head and neck surgery was not prospectively determined.
Cohort (n=47)
No
The incidence of clinically significant venous thromboembolism in patients undergoing major head and neck cancer surgery without routine anticoagulation was 6% at 30 days, which is slightly higher than previously estimated.
Answers are grounded in this paper and cite their sources.
May warrant thromboprophylaxis consideration after major head and neck cancer surgery; leaves open optimal regimens from randomized trials.
OBJECTIVES: To prospectively determine the incidence of venous thromboembolism (VTE) following major head and neck surgery. At the midpoint of enrollment, an interim analysis was performed to determine if it was ethical to continue this study as an observational study without routine anticoagulation. DESIGN: Prospective, observational cohort study. SETTING: Academic surgical center. PATIENTS: The interim analysis comprised 47 subjects. MAIN OUTCOME MEASURE: The total number of new cases of VTE (superficial and deep) identified within 30 days of surgery and confirmed on diagnostic imaging. These cases were further categorized as clinically relevant and nonclinically relevant. Clinically relevant VTEs were those requiring more than 6 weeks of anticoagulation or were associated with any negative impact on clinical course. On postoperative day 2 or 3, subjects were clinically examined and received duplex ultrasonography. Subjects with negative findings from examination and ultrasonography were followed up clinically; subjects with evidence of deep venous thrombus or pulmonary embolism were given therapeutic anticoagulation. Subjects with superficial VTE received repeated ultrasonography on postoperative days 4 to 6. Subjects were monitored for 30 days after surgery. RESULTS: Three subjects (6%) were identified as having clinically significant VTE: 2 cases of deep venous thrombus and 1 case of pulmonary embolism. Two additional subjects had lower extremity superficial VTE without clinical findings, which were detected by ultrasonography alone. No statistically significant differences were seen between patients with VTE and those without VTE. CONCLUSIONS: This interim analysis of the first prospective study of the incidence of VTE in patients with head and neck cancer showed a VTE rate slightly higher than previously estimated in retrospective studies. There have been no unexpected serious adverse events and no rationale for early termination of the study.
No takes yet. Share an insight, caveat, or question.
Clayburgh et al. (2013) conducted a cohort in Head and neck cancer (n=47). Major head and neck surgery was evaluated on Total number of new cases of VTE (superficial and deep) identified within 30 days of surgery. Major head and neck surgery in cancer patients was associated with a 6% incidence of clinically significant venous thromboembolism within 30 days postoperatively.
Synapse has enriched 10 related papers. Consider them for comparative context: